1. Home
  2. BCAB vs WRAP Comparison

BCAB vs WRAP Comparison

Compare BCAB & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • WRAP
  • Stock Information
  • Founded
  • BCAB 2007
  • WRAP 2016
  • Country
  • BCAB United States
  • WRAP United States
  • Employees
  • BCAB N/A
  • WRAP N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • WRAP Ordnance And Accessories
  • Sector
  • BCAB Health Care
  • WRAP Industrials
  • Exchange
  • BCAB Nasdaq
  • WRAP Nasdaq
  • Market Cap
  • BCAB 96.2M
  • WRAP 68.8M
  • IPO Year
  • BCAB 2020
  • WRAP N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • WRAP $1.71
  • Analyst Decision
  • BCAB Strong Buy
  • WRAP
  • Analyst Count
  • BCAB 2
  • WRAP 0
  • Target Price
  • BCAB $6.00
  • WRAP N/A
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • WRAP 191.1K
  • Earning Date
  • BCAB 11-08-2024
  • WRAP 10-15-2024
  • Dividend Yield
  • BCAB N/A
  • WRAP N/A
  • EPS Growth
  • BCAB N/A
  • WRAP N/A
  • EPS
  • BCAB N/A
  • WRAP N/A
  • Revenue
  • BCAB N/A
  • WRAP $7,269,000.00
  • Revenue This Year
  • BCAB N/A
  • WRAP N/A
  • Revenue Next Year
  • BCAB N/A
  • WRAP N/A
  • P/E Ratio
  • BCAB N/A
  • WRAP N/A
  • Revenue Growth
  • BCAB N/A
  • WRAP 0.99
  • 52 Week Low
  • BCAB $1.14
  • WRAP $1.21
  • 52 Week High
  • BCAB $4.02
  • WRAP $7.01
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • WRAP 56.79
  • Support Level
  • BCAB $1.87
  • WRAP $1.71
  • Resistance Level
  • BCAB $2.13
  • WRAP $1.93
  • Average True Range (ATR)
  • BCAB 0.12
  • WRAP 0.16
  • MACD
  • BCAB 0.00
  • WRAP 0.01
  • Stochastic Oscillator
  • BCAB 68.90
  • WRAP 61.70

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

Share on Social Networks: